Product Details :

• Despite significant improvements in the quality and efficacy of haemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. supporting nephrologists worldwide in reducing their patients’ risks for cardiovascularmorbidity and mortality.Innovative membranes like Polysulfone and Helixone , modern monitoring devices like the Blood Volume Monitor, the Blood Temperature Monitor and Online Clearance Monitoring (OCM ), ultrapure dialysis fluid prepared modern ONLINE haemodiafiltration systems support the reduction of CVD risk factors.
• Moreover, one of our major goals in coming years is the development and implementation of innovative newtherapies and products that further improve the cardiovascular prognosis of dialysis patients.The quality and purity of the dialysis fluid are of major concern in modern-day renal replacement therapies, as large volumes of dialysis fluid come into contact with the patient’s bloodstream during each treatment.
• Bacterial endotoxins present in contaminated dialysis fluid may elicit undesirable acute reactions and influence the long-term outcome of patients on chronic haemodialysis. Although water used for the production of dialysis fluid istreated by a series of purification steps, it still may not meetthe stringent requirements on bacterial contamination levels laid down by various regulatory bodies.
• By the application of special filters that are highly efficient inretaining bacterial contamination, the required purity grades of dialysis fluid can be achieved easily.
• The fluid filter, located at the end of the water treatment chain, ensures the safe production of ultrapure dialysis fluid. This is attributed to the excellent endo toxin retention capabilities of its Polysulfone fibers.

Product Details :

• Despite significant improvements in the quality and efficacy of haemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. supporting nephrologists worldwide in reducing their patients’ risks for cardiovascularmorbidity and mortality.Innovative membranes like Polysulfone and Helixone , modern monitoring devices like the Blood Volume Monitor, the Blood Temperature Monitor and Online Clearance Monitoring (OCM ), ultrapure dialysis fluid prepared modern ONLINE haemodiafiltration systems support the reduction of CVD risk factors.
• Moreover, one of our major goals in coming years is the development and implementation of innovative newtherapies and products that further improve the cardiovascular prognosis of dialysis patients.The quality and purity of the dialysis fluid are of major concern in modern-day renal replacement therapies, as large volumes of dialysis fluid come into contact with the patient’s bloodstream during each treatment.
• Bacterial endotoxins present in contaminated dialysis fluid may elicit undesirable acute reactions and influence the long-term outcome of patients on chronic haemodialysis. Although water used for the production of dialysis fluid istreated by a series of purification steps, it still may not meetthe stringent requirements on bacterial contamination levels laid down by various regulatory bodies.
• By the application of special filters that are highly efficient inretaining bacterial contamination, the required purity grades of dialysis fluid can be achieved easily.
• The fluid filter, located at the end of the water treatment chain, ensures the safe production of ultrapure dialysis fluid. This is attributed to the excellent endo toxin retention capabilities of its Polysulfone fibers.